TG Therapeutics, Inc. SEC filings TGTX
TG Therapeutics, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Feb 28, 2003. Its latest annual report, Form 10-K, was filed on Feb 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 8, 2025 | — |
| S-3ASR | Automatic shelf registration | Aug 8, 2025 | — |
| S-3ASR | Automatic shelf registration | Sep 2, 2022 | — |
| S-8 | Employee stock plan registration | Jun 24, 2022 | — |
| 424B5 | Prospectus supplement | Dec 16, 2020 | — |
| 424B5 | Prospectus supplement | Dec 14, 2020 | — |
| 424B5 | Prospectus supplement | Nov 9, 2020 | — |
| 424B5 | Prospectus supplement | May 18, 2020 | — |
| 424B5 | Prospectus supplement | May 14, 2020 | — |
| 424B5 | Prospectus supplement | Mar 20, 2020 | — |
| 424B5 | Prospectus supplement | Dec 23, 2019 | — |
| S-3ASR | Automatic shelf registration | Sep 5, 2019 | — |
| S-3 | Shelf registration | Aug 30, 2019 | — |
| 424B5 | Prospectus supplement | Mar 5, 2019 | — |
| 424B5 | Prospectus supplement | Feb 28, 2019 | — |
| S-3 | Shelf registration | Jul 9, 2018 | — |
| S-8 | Employee stock plan registration | Jun 25, 2018 | — |
| S-3/A | S-3 | Jun 9, 2017 | — |
| S-3 | Shelf registration | May 26, 2017 | — |
| 424B5 | Prospectus supplement | Mar 10, 2017 | — |
| 424B5 | Prospectus supplement | Mar 8, 2017 | — |
| S-8 | Employee stock plan registration | Mar 15, 2016 | — |
| 424B1 | Filing | Dec 31, 2015 | — |
| S-3 | Shelf registration | Dec 31, 2014 | — |
| 424B5 | Prospectus supplement | Mar 12, 2014 | — |
| 424B5 | Prospectus supplement | Jul 18, 2013 | — |
| 424B5 | Prospectus supplement | Jul 17, 2013 | — |
| 424B5 | Prospectus supplement | Jun 21, 2013 | — |
| S-3 | Shelf registration | May 31, 2013 | — |
| S-8 | Employee stock plan registration | May 15, 2012 | — |
| 424B3 | Prospectus | Jul 6, 2010 | — |
| 424B3 | Prospectus | Jul 6, 2010 | — |
| POS AM | Filing | Jun 24, 2010 | — |
| POS AM | Filing | Jun 24, 2010 | — |
| 424B3 | Prospectus | Jun 18, 2010 | — |
| S-1 | Registration statement | Jun 7, 2010 | — |
| S-1 | Registration statement | Jun 2, 2009 | — |
| 424B3 | Prospectus | May 19, 2009 | — |
| 424B3 | Prospectus | May 19, 2009 | — |
| POS AM | Filing | May 5, 2009 | — |
| 424B3 | Prospectus | Apr 20, 2009 | — |
| 424B3 | Prospectus | Apr 14, 2009 | — |
| S-1/A | Amended registration statement | Apr 10, 2009 | — |
| S-1 | Registration statement | Feb 23, 2009 | — |
| 424B3 | Prospectus | Feb 4, 2009 | — |
| 424B3 | Prospectus | Jan 28, 2009 | — |
| 424B3 | Prospectus | Jan 22, 2009 | — |
| 424B3 | Prospectus | Jan 21, 2009 | — |
| 424B3 | Prospectus | Nov 26, 2008 | — |
| 424B3 | Prospectus | Nov 21, 2008 | — |
| 424B3 | Prospectus | Oct 16, 2008 | — |
| S-1/A | Amended registration statement | Oct 3, 2008 | — |
| S-1 | Registration statement | May 1, 2008 | — |
| S-8 | Employee stock plan registration | Jun 18, 2007 | — |
| 424B3 | Prospectus | May 22, 2007 | — |
| S-3/A | Filing | May 16, 2007 | — |
| S-3 | Shelf registration | May 9, 2007 | — |
| 424B3 | Prospectus | Apr 10, 2006 | — |
| S-3/A | Filing | Apr 6, 2006 | — |
| S-3 | Shelf registration | Feb 13, 2006 | — |
| 424B3 | Prospectus | Nov 18, 2005 | — |
| 424B3 | Prospectus | Nov 18, 2005 | — |
| 424B3 | Prospectus | Oct 11, 2005 | — |
| 424B3 | Prospectus | Oct 11, 2005 | — |
| POS AM | Filing | Sep 21, 2005 | — |
| 424B3 | Prospectus | Jan 10, 2005 | — |
| 424B3 | Prospectus | Nov 18, 2004 | — |
| 424B3 | Prospectus | Aug 18, 2004 | — |
| S-8 | Employee stock plan registration | Feb 17, 2004 | — |
| S-8 | Employee stock plan registration | Feb 17, 2004 | — |
Showing 70 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TGTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1001316
- Former names
- MANHATTAN PHARMACEUTICALS INC (until Apr 27, 2012); ATLANTIC TECHNOLOGY VENTURES INC (until Mar 10, 2003); ATLANTIC PHARMACEUTICALS INC (until Feb 4, 2000)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.